Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Balance disorder, Blood glucose, Blood glucose increased, Blood test
Clinical narrative: Dizzy; foggy/Brain fog; Pain every where especially hands; severely elevated B.S; Nausea; pain/Severe pain; booster; Fainted; Fainted resulted in concussion, Broken nose; Severe stomach pain; Diarrhea; severe inflammatory reaction; memory problems; unable to process or think clearly; edema; unable to use hands to grip; muscle loss; cant bend fingers make fast; Balance problems; Fainted resulted in concussion, Broken nose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Aug2021 17:00 (Lot number: FC3181) at the age of 52 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Type 1 Diabetes" (unspecified if ongoing); "Hypothyroidism" (unspecified if ongoing); "Cholesterol" (unspecified if ongoing); "Insomnia" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing). Concomitant medication(s) included: HUMALOG taken for type 1 diabetes mellitus (ongoing); LISINOPRIL taken for prophylaxis (ongoing); SYNTHROID taken for hypothyroidism (ongoing); ROSUVASTATIN taken for blood cholesterol abnormal (ongoing); TRAZODONE taken for insomnia (ongoing); DULOXETINE taken for fibromyalgia (ongoing). Vaccination history included: Bnt162b2 (Dose Number:01, Time: 11:00 AM, Anatomical site of injection: Left arm, Route of administration: Intramuscular, Batch/Lot number: EL9262), administration date: 24Jan2021, when the patient was 52 years old, for Covid-19 Immunization, reaction(s): "Joint pain", "Head severe pain", "High Blood sugar", "Brain fog", "Nausea", "Cognitive problems", "Head to toe pain"; Bnt162b2 (Dose Number:02, Time: 10:00 AM, Anatomical site of injection: Right Arm, Route of administration: Intramuscular, Batch/Lot number: EN6202), administration date: 22Feb2021, when the patient was 52 years old, for Covid-19 Immunization, reaction(s): "Joint pain", "Head severe pain", "High Blood sugar", "Brain fog", "Nausea". The following information was reported: IMMUNISATION (disability, medically significant) with onset 21Aug2021, outcome "not recovered", described as "booster"; PAIN IN EXTREMITY (disability, medically significant) with onset 22Aug2021, outcome "not recovered", described as "Pain every where especially hands"; BLOOD GLUCOSE INCREASED (disability) with onset 21Aug2021, outcome "recovered" (26Aug2021), described as "severely elevated B.S"; NAUSEA (disability) with onset 21Aug2021 late evening, outcome "not recovered", described as "Nausea"; PAIN (disability) with onset 21Aug2021, outcome "not recovered", described as "pain/Severe pain"; DIZZINESS (disability) with onset 22Aug2021 AM, outcome "not recovered", described as "Dizzy"; FEELING ABNORMAL (disability) with onset 22Aug2021 AM, outcome "not recovered", described as "foggy/Brain fog"; LOSS OF CONSCIOUSNESS (medically significant) with onset Aug2021 (23Aug2021-24Aug2021 middle of night), outcome "not recovered", described as "Fainted"; FACIAL BONES FRACTURE (medically significant), CONCUSSION (non-serious) all with onset Aug2021, outcome "not recovered" and all described as "Fainted resulted in concussion, Broken nose"; ABDOMINAL PAIN UPPER (non-serious) with onset Aug2021, outcome "not recovered", described as "Severe stomach pain"; DIARRHOEA (non-serious) with onset Aug2021, outcome "not recovered", described as "Diarrhea"; INFLAMMATION (non-serious) with onset Aug2021, outcome "not recovered", described as "severe inflammatory reaction"; MEMORY IMPAIRMENT (non-serious) with onset Aug2021, outcome "not recovered", described as "memory problems"; THINKING ABNORMAL (non-serious) with onset Aug2021, outcome "not recovered", described as "unable to process or think clearly"; OEDEMA (non-serious) with onset Aug2021, outcome "not recovered", described as "edema"; GRIP STRENGTH DECREASED (non-serious) with onset Aug2021, outcome "not recovered", described as "unable to use hands to grip"; MUSCLE ATROPHY (non-serious) with onset Aug2021, outcome "not recovered", described as "muscle loss"; JOINT RANGE OF MOTION DECREASED (non-serious) with onset Aug2021, outcome "not recovered", described as "cant bend fingers make fast"; BALANCE DISORDER (non-serious) with onset Aug2021, outcome "not recovered", described as "Balance problems". The patient had not recovered from the 3rd dose reaction, despite continuing therapies. The events "booster", "pain every where especially hands", "severely elevated b.s", "nausea", "dizzy", "foggy/brain fog", "fainted", "fainted resulted in concussion, broken nose", "severe stomach pain", "diarrhea", "severe inflammatory reaction", "memory problems", "unable to process or think clearly", "edema", "unable to use hands to grip", "muscle loss", "cant bend fingers make fast", "balance problems" and "fainted resulted in concussion, broken nose" were evaluated at the physician office visit. Saw concussion specialist (Neurologist and Hand surgeon in Oct2021 and Endocrinologist). Currently being treated with occupational therapy, physical therapy, speech therapy. Hand specialist put her on 6 day course on prednisone(oral) for inflammation. All is ongoing. The patient underwent the following laboratory tests and procedures: blood test: (Oct2021) unknown results; computerised tomogram: (Sep2021) unknown results; magnetic resonance imaging: (Oct2021) unknown results; sars-cov-2 test: (unspecified date) negative; blood glucose: (21Aug2021) increased. Therapeutic measures were taken as a result of pain in extremity (Read back), blood glucose increased (insulin increased, fluids), nausea/ pain/ dizziness/ feeling abnormal (PT, OT, ST ongoing), loss of consciousness, facial bones fracture, abdominal pain upper, diarrhoea, inflammation, memory impairment, thinking abnormal, oedema, grip strength decreased, muscle atrophy, joint range of motion decreased, balance disorder, concussion.  Follow-up attempts are completed. No further information is expected.